NCT02674347View on ClinicalTrials.gov

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy Subjects
Interventions
DRUG

3 g or 6 g Zidebactam

IV for over a duration of 60 minutes

DRUG

Placebo

IV matching the Investigational drug

Trial Locations (1)

66211

Quintiles, Overland Park

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Wockhardt

INDUSTRY

NCT02674347 - MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults | Biotech Hunter | Biotech Hunter